Increase testosterone for strength

Veedma is a modern preventive telehealth clinic focused on hormone health, sexual health, and well-being.

For men, that means finding the cause of your symptoms before treating them. Low sex drive, weak erections, fatigue, belly fat, low mood, and brain fog can come from low testosterone, and they can just as easily come from a thyroid problem, insulin resistance, iron deficiency, low vitamin D, or sleep apnea. Most clinics check whether you qualify for testosterone and stop there. Our medical team reads your labs together with your symptoms and medical history to work out what is actually driving them.

When testosterone is low, we find out why and restore your own production with Enclomiphene where the pattern allows, preserving your fertility. When the cause is somewhere else, we can treat that too. Our protocols follow national guidelines from the American Urological Association (AUA), the American Association of Clinical Endocrinology (AACE), and the Endocrine Society.

A testosterone blood test at Veedma starts at $59 for your first Men's Optimal Health Lab Test, and it tests far more than testosterone: 65 biomarkers including Total and Free Testosterone by LC-MS/MS with equilibrium dialysis, Estradiol, LH, FSH, PSA, a complete blood count with differential, liver, kidney and electrolyte panels, a cholesterol panel, and blood sugar.

The Men's Biohacking Lab Test is $409 and covers 103 biomarkers: everything in Optimal plus thyroid (TSH, Free T3, Free T4 and antibodies), fasting insulin and HbA1c, ApoB, ApoA1, hsCRP and homocysteine, an omega-3 and omega-6 profile, iron, ferritin, B12, folate, vitamin D, magnesium and zinc, prolactin and DHEA-S, heavy metals, and an ANA autoimmune screen.

Both prices include the blood draw at Quest Diagnostics, a written report from our medical team, and the video visit with a licensed doctor. Labs are billed at what the lab charges us, and for new patients we take an additional $30 off the Optimal panel. Lab panels are FSA/HSA eligible.

Testosterone replacement therapy (TRT), whether by injection, cream, or oral tablet, replaces the hormone directly. Enclomiphene works upstream. It blocks estrogen receptors in the hypothalamus and pituitary, which removes the brake estrogen puts on the system: the hypothalamus releases more GnRH, the pituitary releases more LH and FSH, and those two hormones tell your testes to make your own testosterone and produce sperm.

TRT is the right tool for primary hypogonadism, actual testicular failure, where LH and FSH are elevated because the testes are not responding to the signal. Most men with low testosterone do not have that problem. Their testes still work, and the pituitary signal is suppressed by extra body weight, poor sleep, chronic stress, sleep apnea, type 2 diabetes, or certain medications. This pattern is called secondary or functional hypogonadism, and about 86% of men with low testosterone have it (European Male Ageing Study, Tajar et al., Journal of Clinical Endocrinology & Metabolism, 2010).

For these men, exogenous testosterone shuts down the pituitary signal entirely. Over months on TRT the testes atrophy, sperm production is suppressed, and fertility is compromised, sometimes for good. Coming off TRT is much harder than starting it. Veedma's workup separates the primary from the secondary pattern from your labs and history before any treatment starts.

Clomiphene (Clomid) is a fertility drug developed for women. It triggers ovulation with a 5-day course once per cycle, and it works well for that. It is a mix of two molecules: about 62% enclomiphene and 38% zuclomiphene (FDA prescribing information).

Enclomiphene is the half that is useful for men. It blocks estrogen receptors in the brain, so the pituitary releases more LH and FSH and your testes make more of your own testosterone. Zuclomiphene is the problem half for men. It acts like a weak estrogen, works against the effect you want, and clears very slowly: detectable levels last more than a month, while enclomiphene is gone in about 10 hours. On a 5-day course that does not matter. A man with low testosterone takes the drug every day for months, so zuclomiphene builds up. The side effects men report on long-term Clomid, mood swings, hot flashes, breast tenderness, and visual disturbances, are thought to come from that estrogen-like build-up. Clomid is a poor fit for daily, long-term use in men.

Enclomiphene was isolated from that mix and developed as a standalone drug specifically for men with secondary hypogonadism. In trials it raised testosterone into the normal range while keeping sperm counts normal (Wiehle et al., Fertility and Sterility, 2014; Kaminetsky et al., BJU International, 2016), and a 2025 meta-analysis of 10 randomized trials found SERM therapy raised total testosterone by 274 ng/dL over placebo while preserving sperm production (Hohl et al., Archives of Endocrinology and Metabolism, 2025).

Enclomiphene is available only from compounding pharmacies, so no insurance covers it and most primary care doctors never prescribe it. Veedma prescribes it as the first-line testosterone treatment, works with compounding pharmacies that make it, and monitors every man on it with follow-up labs after the first month and every 6 months.

They look similar because both raise testosterone, and they are not interchangeable.

Enclomiphene works in one place. It blocks estrogen receptors in the hypothalamus, which tricks the brain into releasing more LH and FSH, and your testes make more testosterone. Every other cell in your body still sees your estradiol, and men need it: for libido and erections, bone density, body fat control, and mood (Finkelstein et al., New England Journal of Medicine, 2013). On enclomiphene you keep those benefits while your own testosterone rises.

Anastrozole works everywhere. It is an aromatase inhibitor, a breast cancer drug that blocks the enzyme that makes estradiol, so estradiol falls in every tissue at once. Testosterone goes up, and your body runs close to no estrogen. That is why men on it lose bone density (Burnett-Bowie et al., Journal of Clinical Endocrinology & Metabolism, 2009) and often feel worse: joint aches, low libido, flat mood.

Anastrozole only makes sense as a small add-on when estradiol is genuinely high, with symptoms, and adjusting the enclomiphene dose has not brought it down. Our medical team uses the minimum needed to control estradiol and stops it when the level normalizes. It is never a substitute for enclomiphene.

1. Order your lab panel. Choose the Optimal or Biohacking panel and book a morning blood draw at any of 2,000+ Quest Diagnostics locations. Already have recent labs? Upload them instead for a free review.
2. Get your results and report. While your lab results are being processed, you submit your medical history. Once everything is ready, our medical team sends you a written report on what each number means and which treatment options fit.
3. Meet your doctor. If your report shows you are eligible, you select a membership plan (card saved, nothing charged) and book a video visit. A licensed doctor goes through your labs, symptoms, and medical history with you and, if treatment is right for you, writes the prescription.
4. Start treatment. When the prescription is sent, your plan activates and your medication ships from our NABP-accredited partner pharmacy.
5. Follow-up. Labs are re-checked after the first month and then every 6 months, and your doctor adjusts the dose on real numbers.

The Enclomiphene + Tadalafil combination tablet is a single daily oral medication compounded by our NABP-accredited partner pharmacy. It combines two evidence-supported components:

• Enclomiphene. Blocks estrogen receptors in the hypothalamus and pituitary, so the pituitary releases more LH and FSH, stimulating your body's own testosterone production and supporting sperm production. Prescribed off-label and supported by the American Urological Association (AUA) as SERM therapy for men with secondary or functional hypogonadism.
• Tadalafil 5 mg. A PDE5 inhibitor that improves blood flow for erections. FDA-approved for daily use to treat erectile dysfunction and the urinary symptoms of benign prostatic hyperplasia (BPH).

The combination tablet is prescribed when low testosterone comes with erection difficulties or urinary symptoms. One tablet, once a day, no separate prescriptions to manage.

No. The lab panel price covers the blood draw, the written report, and the video visit with a doctor, and nothing is charged for a plan until a doctor prescribes treatment. If your report shows you are eligible for treatment, you select a membership plan and save a card before booking the visit. Nothing is charged at that step, and the visit costs nothing.

The membership starts only if the doctor prescribes treatment at the end of the visit. When the prescription is sent, your plan activates and your card is charged. If the doctor decides treatment is not right for you, or you decide against it during the visit, nothing is charged and no plan starts. You keep the report and the doctor's recommendations.

Lab panels are a separate payment and are non-refundable once the blood draw is collected, because they cover lab work and clinical analysis already performed.

Membership is $79 a month on an annual plan, $129 a month on a quarterly plan, or $159 a month with no commitment. The price is flat for any dose, and it starts only when a doctor prescribes treatment.

Every plan includes:

• Daily medication. Enclomiphene, or the Enclomiphene + Tadalafil combination tablet, at whatever dose your doctor sets.
• Additional medication when your labs call for it. Anastrozole for high estradiol, for example, is included; there is no separate charge.
• Doctor reviews. Your doctor reads every follow-up panel, adjusts the dose, and reissues your prescription; no separate visit fees.
• Lab interpretation. A written report from our medical team after each follow-up panel, on what changed and what it means.
• Unlimited messaging with your care team.
• Delivery from our NABP-accredited partner pharmacy.

Lab work is separate: your initial Optimal panel is $59, and follow-up panels are billed at lab cost or replaced by results you upload. There is no hidden cost. Membership and labs are both FSA/HSA eligible.

Yes. If you have results from Function Health, Superpower, InsideTracker, Marek Health, Hone, Everlywell, Quest Diagnostics, Labcorp, or any other lab or wellness panel drawn in the past 180 days, upload them for a free clinical review. Our medical team returns a written report within 24 hours on business days (up to 48 hours on weekends and holidays). No credit card, no obligation. From there the path is the same as for men who order our panel: if the report shows you are eligible, you select a plan, book the video visit at no charge, and pay only if the doctor prescribes treatment.

To reach a treatment decision, the upload has to include Total Testosterone, Free Testosterone (measured, or calculated from SHBG and albumin), LH, a complete blood count or hematocrit, and PSA if you are 40 or older. If something is missing, the report says exactly which markers to add.

Consumer lab services like Function Health and Superpower give you the data (often 100+ biomarkers) without a clinician to read it. Our review covers the hormone pattern (how Free Testosterone, LH, FSH, and SHBG relate), symptom drivers beyond testosterone (thyroid, prolactin, vitamin D, iron and ferritin, glucose, insulin, lipids), whether Enclomiphene fits your pattern, and a clear next step: treatment, more testing, or no action needed.

Our medical team treats testosterone deficiency when free testosterone is below 100 pg/mL, measured by LC-MS/MS or calculated from SHBG and albumin, and you have persistent symptoms. Both are required; a number alone is never a diagnosis. LH and FSH show whether the pituitary signal is low (secondary or functional hypogonadism, which Enclomiphene can address) or the testes themselves are failing (primary hypogonadism, where replacement therapy is the right tool).

Safety markers can rule treatment out: hematocrit, PSA for men 40 and older, and prolactin when it was measured. In that case the report explains the finding and who should evaluate it.

If your free testosterone is 100 pg/mL or above, raising it further rarely helps, and our medical team says so. Either way, you get the report and a recommendation.

Then the report says so, and it says what is. The same symptoms often come from a thyroid problem, insulin resistance, iron deficiency, low vitamin D, or sleep apnea, and the two lab panels are built to find them: the Optimal panel covers the hormone axis and safety markers, and the Biohacking panel adds thyroid, insulin resistance, inflammation, nutrients, and heavy metals.

When we find one of these, we can treat it as an add-on to your plan: thyroid medication, metformin for insulin resistance, iron or vitamin D repletion, or a referral for sleep apnea testing. Where testosterone is normal and erections or urinary symptoms are the problem, daily Tadalafil on its own is an option your doctor can discuss.

Total and Free Testosterone on every Veedma panel are measured by LC-MS/MS with equilibrium dialysis, the reference method the Endocrine Society recommends and the method clinical research uses. The draw is in person at a CLIA-certified Quest Diagnostics location.

Our treatment thresholds come from published research, so your result has to be measured the way the research measured it. A widely used clinical immunoassay reads testosterone about 20% lower than LC-MS/MS, and below 100 ng/dL it barely tracks the true value (Shi et al., Journal of Chromatography B, 2021; Martínez-Escribano et al., Biomolecules, 2020). That error sits exactly where the treatment decision is made.

The same reason rules out finger-prick home kits. Capillary collection tubes with serum separator gel read testosterone 14% and estradiol 19% lower than a venous draw (Vasavan et al., Journal of Applied Laboratory Medicine, 2025). Close enough for general wellness, too far off for a treatment decision.

Most men's health clinics fall into two categories. TRT-first clinics (Hone Health, TRT Nation, PeterMD) default to testosterone replacement after minimal evaluation. Questionnaire-based services (Hims, Maximus) prescribe from a health questionnaire and an at-home lab kit, with doctor contact by messaging and a video visit only where a state requires one, so you may never speak to the doctor who prescribes for you. Veedma sits in neither category. We're a preventive telehealth clinic built on five differentiators:

1. Natural stimulation before replacement. We start with Enclomiphene to restore your body's own testosterone production, keep your testes producing, and preserve your fertility. Testosterone replacement is reserved for the minority of cases (primary hypogonadism) where stimulation is not possible.

2. Diagnostics with full clinical context. Labs, medical history, a structured symptom assessment, and a video visit with the doctor who writes your prescription. Together they tell us whether your hormone signal can be restored, your blood flow needs support, or both. A questionnaire alone misses the secondary and functional patterns that about 86% of men with low testosterone have (European Male Ageing Study, Tajar et al., Journal of Clinical Endocrinology & Metabolism, 2010).

3. Right markers, right method. Total and Free Testosterone by LC-MS/MS with equilibrium dialysis, the reference method, on every panel. The Optimal panel adds the hormone axis (Estradiol, LH, FSH), PSA, a complete blood count, liver, kidney, cholesterol, and blood sugar; the Biohacking panel adds thyroid, insulin resistance, inflammation, nutrient, and heavy-metal markers. You pay lab cost, nothing on top.

4. One flat price, whatever your treatment needs. Your monthly price covers medication, doctor reviews, messaging, and delivery, and it does not move. A higher dose costs the same. Adding Tadalafil to your Enclomiphene for erections, or Anastrozole for high estradiol, costs the same. Lab work is the only separate item, billed at lab cost, and you can upload your own results instead.

5. National guidelines as the baseline. Our protocols follow the American Urological Association (AUA), the American Association of Clinical Endocrinology (AACE), and the Endocrine Society, the same standards used in clinical research, applied to your individual care.

The level moves first, the symptoms follow. On Enclomiphene your own testosterone rises over the first few weeks, and the panel between days 30 and 40 confirms where it landed so your doctor can adjust the dose. How you feel changes on its own schedule after that.

The first changes most men report, in weeks 4 to 10, are interest in sex and a steadier mood. Erections become more reliable over months 2 to 6. Strength, body composition, and bone respond from month 3 onward and keep building (Saad et al., European Journal of Endocrinology, 2011; Testosterone Trials, Snyder et al., New England Journal of Medicine, 2016). These timings come from studies of restored testosterone levels in general; how fast you get there depends on your starting level, the cause, and the dose.

Between panels you have unlimited messaging with your care team and a monthly check-in questionnaire, so side effects and symptom changes reach your doctor early. After the first month, labs repeat every 6 months and your doctor reviews each panel.

Yes. Veedma is LegitScript-certified, the standard that pharmacies, telehealth providers, and the major search and ad platforms use to confirm an online healthcare service operates legally and safely; you can verify our certification on LegitScript's website. Every Veedma doctor is licensed and specializes in men's hormone, sexual, and fertility health. Every prescription is written by a doctor licensed to prescribe in your state, after a video visit that reviews your symptoms, labs, and medical history, and is filled by our NABP-accredited partner pharmacy.

Safety is built into the protocol: hematocrit and PSA are checked before treatment and on every follow-up panel, estradiol is tracked so your doctor can respond to it, and treatment follows the American Urological Association (AUA), the American Association of Clinical Endocrinology (AACE), and the Endocrine Society guidelines.

Yes. Your health information is protected under HIPAA and the California Confidentiality of Medical Information Act (CMIA). It is treated as protected health information from the moment you share it, including labs you upload before any treatment relationship, handled only as those laws permit, and we do not sell your personal information. See our Privacy policy for the full detail.

Veedma is a direct-pay clinic and does not bill insurance. Enclomiphene is generally not covered by insurance for hypogonadism because it is prescribed off-label, and a flat membership is often less than the copays for separate doctor visits, labs, and medication combined.

Both the membership and the lab panels are FSA/HSA eligible: they qualify as medical expenses, so you can pay with pre-tax dollars from a Flexible Spending Account or Health Savings Account.

Veedma serves patients in most U.S. states. We currently do not operate in Alabama, Alaska, District of Columbia, Hawaii, Mississippi, New Jersey, New York, Oklahoma, Rhode Island, Utah, or Wisconsin. Your state is confirmed at checkout, since coverage changes as we onboard additional licensed doctors.